Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Loading...
Loading...

Gainers

  • PainReform Ltd. PRFX jumped 45.5% to $10.34 after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements.
  • T2 Biosystems, Inc. TTOO shares gained 22.8% to $0.1255 after the FDA granted Breakthrough Device designation for the company's Candida auris direct-from-blood molecular diagnostic test.
  • SigmaTron International, Inc. SGMA shares climbed 25.3% to $4.4861 after the company reported results for the fourth quarter.
  • Pasithea Therapeutics Corp. KTTA gained 21% to $0.5790 after the company rejected an unsolicited, non-binding acquisition proposal from Lucy Scientific Discovery. The company also authorized the repurchase of up to 5.7 million shares at $0.70/share.
  • Kuke Music Holding Limited KUKE climbed 16.5% to $0.55.
  • Dynatronics Corporation DYNT climbed 15% to $0.8998.
  • Lytus Technologies Holdings PTV. Ltd. LYT shares gained 14.4% to $0.5434 after gaining around 14% on Wednesday.
  • Gorilla Technology Group Inc. GRRR rose 14.4% to $2.61 after the company announced a strategic relationship with British Telecom to deliver an AI-powered innovative Smart Port solution.
  • Tarsus Pharmaceuticals, Inc. TARS gained 12.3% to $22.59.
  • Theseus Pharmaceuticals, Inc. THRX rose 11.6% to $3.54.
  • Catalyst Biosciences, Inc. CBIO gained 11.2% to $0.4099.
  • Heritage-Crystal Clean, Inc HCCI climbed 9.6% to $45.96 after the company announced it will be acquired by J.F. Lehman & Company for $1.2 billion.
  • Zions Bancorporation, National Association ZION rose 9.4% to $37.72 after the company reported second-quarter earnings results.
  • Select Medical Holdings Corporation SEM gained 9.1% to $32.87.
  • Nanobiotix S.A. NBTX shares climbed 8.4% to $7.77 as the company said first patient was injected in new Phase 1/2 study evaluating radiotherapy-activated NBTXR3 plus anti-PD-1 for patients with advanced cancers.
  • Singularity Future Technology Ltd. SGLY gained 8% to $0.50.

Losers

  • Vir Biotechnology, Inc. VIR shares fell 43.4% to $13.04 after the company's Phase 2 PENINSULA trial of VIR-2482 for the prevention of symptomatic influenza A illness did not meet primary or secondary efficacy endpoints.
  • Netcapital Inc. NCPL fell 40.2% to $0.70 after the company announced pricing of a public offering.
  • Aspira Women's Health Inc. AWH fell 30.6% to $2.76 after the company announced a registered direct offering of around 1.7 million shares at $2.75 per share and $3.98 per share for directors & officers, for gross proceeds of approximately $4.7 million.
  • DURECT Corporation DRRX dipped 29.9% to $3.45 after the company announced a $15 million registered direct offering priced at-the-market under Nasdaq rules.
  • Cosmos Health Inc. COSM declined 22.5% to $1.9199 after the company priced $5.25 million registered direct offering and concurrent private placement at combined price of $2.48.
  • NVE Corporation NVEC shares tumbled 17% to $80.18 following first-quarter results.
  • Alpine Summit Energy Partners, Inc. ALPS fell 16.8% to $0.1483 after declining around 8% on Wednesday. The company recently filed for voluntary chapter 11 relief in the U.S. Bankruptcy Court for the Southern District of Texas, Houston Division.
  • JX Luxventure Limited JXJT shares fell 16.6% to $2.16. JX Luxventure shares gained 11% on Wednesday after the company reported a new artificial intelligence initiative.
  • Discover Financial Services DFS fell 14.7% to $104.00 after the company reported downbeat quarterly earnings and announced a share buyback pause.
  • Richardson Electronics, Ltd. RELL fell 13.3% to $13.49 after the company reported worse-than-expected fourth-quarter earnings results.
  • Mallinckrodt plc MNK declined 12.5% to $0.5950.
  • 60 Degrees Pharmaceuticals, Inc. SXTP shares tumbled 12.4% to $2.8893.
  • Vroom, Inc. VRM fell 11.4% to $2.3650.
  • Infosys Limited INFY shares declined 9.4% to $16.05 after the company reported worse-than-expected quarterly earnings results.
  • Ginkgo Bioworks Holdings, Inc. DNA declined 8.8% to $2.3150. Ginkgo Bioworks was granted a four-year contract by the Defense Advanced Research Projects Agency (DARPA) worth up to $18 million.
  • Quantum-Si incorporated QSI fell 8.7% to $3.24.
  • Netflix, Inc. NFLX fell 8.4% to $437.57. Netflix reported upbeat earnings for the second quarter, while sales missed expectations.
  • Mobileye Global Inc. MBLY tumbled 8.2% to $39.93.
  • ABVC BioPharma, Inc. ABVC fell 7.9% to $0.3869.
  • Columbia Banking System, Inc. COLB declined 7.7% to $21.73 after the company reported worse-than-expected second-quarter EPS results.
  • ManpowerGroup Inc. MAN fell 7.5% to $82.18 following weak quarterly earnings.
  • SL Green Realty Corp. SLG shares fell 7% to $33.45 after the company reported lower-than-expected Q2 sales results.
  • Genuine Parts Company GPC declined 6.5% to $157.16 following second-quarter results.
  • Tesla, Inc. TSLA fell 6.4% to $272.65. Tesla reported better-than-expected earnings and sales results for its second quarter, but said operating margin narrowed to 9.6% from 14.6% in the year-ago period.
  • Carvana Co. CVNA dipped 6.2% to $52.33. RBC Capital downgraded Carvana from Sector Perform to Underperform and raised the price target from $9 to $30.
  • Super Micro Computer, Inc. SMCI declined 5.8% to $285.79. Supermicro announced preliminary financial results for the fourth quarter.
  • Crown Castle Inc. CCI shares fell 5.8% to $106.88 after the company reported second-quarter results and issued weak FY23 earnings outlook.

 

Now Read This: Check Out 3 High-Yielding Dividend Stocks In Tech And Telecom Sector From Wall Street's Most Accurate Analysts

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasHuman Resource & Employment ServicesIndustrialsMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...